Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.31 |
| ▸ | KDR | P35968 | 2/20 | 0.31 |
| ▸ | P4HB | P07237 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25751940 | 0.88 | LPL (0.38) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL21764715 | 0.80 | LPL (0.46) | LPLLIPGPRMT5WDR77PDGFRB | |
| SCHEMBL21385268 | 0.77 | LIPG (0.42) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL21382836 | 0.77 | LIPG (0.42) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL2228128 | 0.77 | LPL (0.49) | LPLLIPGPDGFRBKDR | |
| SCHEMBL203692 | 0.73 | LIPG (0.51) | LPLLIPGP4HB | |
| SCHEMBL21383200 | 0.73 | LPL (0.32) | LPLLIPG | |
| SCHEMBL21383207 | 0.73 | LIPG (0.37) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL25908302 | 0.71 | KDM4E (0.53) | LPLLIPGPRMT5WDR77PDGFRB | |
| SCHEMBL32675819 | 0.70 | LPL (0.41) | LPLLIPGPRMT5WDR77P4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11683979-B2 | Electroactive materials | LG CHEM, LTD. | 2023-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11683979-B2 | Electroactive materials | NR4A3, NCOA4, NR4A2 | LPL 4084/4885LIPG 4772/4885PRMT5 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.